A U.S. senator is asking the FDA how it will enforce regulations on pharmaceutical advertising after it let go of numerous ...

The criticism of The Lancet, NEJM and JAMA is not new, but the health secretary may use his position to influence research ...

HHS Secretary Robert F. Kennedy Jr. announced that he has unilaterally struck the recommendation that healthy children and ...

The custom-built gene editing treatment for 6-month-old KJ Muldoon could not have come at a more welcome or jarring time for ...

Across New England and the country, thousands of budding scientists have awoken to a stark new reality, following funding ...

A patient in a Rocket Pharmaceuticals gene therapy trial for a rare heart condition has died, the company said.

Last week, I was flipping through the newly filed financial documents of AdventHealth, and the numbers hit me like an ...

In today's D.C. Diagnosis newsletter, layoffs hit the National Academies, and a look at what's already been lost from firings ...

Digital physical therapy company Hinge Health went public last week, raising $437 million and ending an IPO drought for ...

Biogen and City Therapeutics, a privately held developer of RNA-based “trigger molecules,” announced a partnership to develop ...

Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It ...

As a public health official, Jay K. Varma has handled putative anthrax attacks. He says an AI-simulated bioterror attack ...